Skip to main content

Table 1 Characteristics of participants in NHANES

From: Interplay of chronic obstructive pulmonary disease and colorectal cancer development: unravelling the mediating role of fatty acids through a comprehensive multi-omics analysis

Characteristics

According to COPD

According to colon cancer

Non COPD (N = 1688)

COPD (N = 41)

P

Non colon cancer (N = 1718)

Colon cancer (N = 11)

P

Overall Omega-3 fatty acids (µmol/l)

235.4 (179.4, 311.5)

240.6 (167.0, 344.2)

0.87

235.4 (178.7, 311.2)

330.7 (202.8, 421)

0.35

 Alpha-linolenic acid (µmol/l)

61.5 (46.3, 85.3)

59.7 (39.7, 73.6)

0.34

61.2 (46.2, 84.7)

60.9 (41.2, 102)

0.72

 Eicosapentaenoic acid (µmol/l)

41 (29.1, 60.2)

50.5 (33.0, 63.7)

0.18

41.0 (29.2, 60.4)

57.8 (35.6, 68.3)

0.21

 Docosahexaenoic acid (µmol/l)

121 (91.6, 168)

124 (84.1, 167)

0.96

121 (91.4, 168)

183 (124, 212)

0.24

Overall Omega-6 fatty acids (µmol/l)

4252 (3739, 4860)

3997 (3456, 4750)

0.05

4246 (3731, 4850)

4232 (3754, 5460)

0.92

 Linoleic acid (µmol/l)

3450 (2980, 3980)

3230 (2710, 3660)

0.004

3450 (2970, 3970)

3340 (2860, 3990)

0.55

 Arachidonic acid (µmol/l)

791 (650, 929)

813 (678, 924)

0.87

791 (650, 928)

921 (624, 1050)

0.38

Ratio Omega-6/Omega-3

18.83 (0.36)

16.94 (1.82)

0.25

18.4 (14.8, 22.5)

15.1 (11.4, 20.9)

0.15

  1. COPD chronic obstructive pulmonary disease
  2. P value < 0.05 was considered statistically significant